117 related articles for article (PubMed ID: 19428600)
1. New insights into the immunopathogenesis of chronic hepatitis C.
Diepolder HM
Antiviral Res; 2009 Jun; 82(3):103-9. PubMed ID: 19428600
[TBL] [Abstract][Full Text] [Related]
2. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
[TBL] [Abstract][Full Text] [Related]
3. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.
Hiroishi K; Ito T; Imawari M
J Gastroenterol Hepatol; 2008 Oct; 23(10):1473-82. PubMed ID: 18761560
[TBL] [Abstract][Full Text] [Related]
4. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.
Heeg MH; Ulsenheimer A; Grüner NH; Zachoval R; Jung MC; Gerlach JT; Raziorrouh B; Schraut W; Horster S; Kauke T; Spannagl M; Diepolder HM
Gastroenterology; 2009 Oct; 137(4):1280-8.e1-6. PubMed ID: 19596013
[TBL] [Abstract][Full Text] [Related]
5. Adaptive immune responses in acute and chronic hepatitis C virus infection.
Bowen DG; Walker CM
Nature; 2005 Aug; 436(7053):946-52. PubMed ID: 16107834
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus (HCV): a review of immunological aspects.
Irshad M; Khushboo I; Singh S; Singh S
Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
[TBL] [Abstract][Full Text] [Related]
7. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses.
Rehermann B
Semin Liver Dis; 2007 May; 27(2):152-60. PubMed ID: 17520515
[TBL] [Abstract][Full Text] [Related]
8. HCV immunopathogenesis: virus-induced strategies against host immunity.
Szabo G; Dolganiuc A
Clin Liver Dis; 2006 Nov; 10(4):753-71. PubMed ID: 17164116
[TBL] [Abstract][Full Text] [Related]
9. T cell response in hepatitis C virus infection.
Neumann-Haefelin C; Blum HE; Chisari FV; Thimme R
J Clin Virol; 2005 Feb; 32(2):75-85. PubMed ID: 15653409
[TBL] [Abstract][Full Text] [Related]
10. [Immunopathogenesis of viral hepatitis].
Neumann-Haefelin C; Thimme R
Praxis (Bern 1994); 2007 Apr; 96(14):545-51. PubMed ID: 17455566
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
Bode JG; Brenndörfer ED; Häussinger D
Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
[TBL] [Abstract][Full Text] [Related]
12. Current and future hepatitis C therapies.
Firpi RJ; Nelson DR
Arch Med Res; 2007 Aug; 38(6):678-90. PubMed ID: 17613359
[TBL] [Abstract][Full Text] [Related]
13. Plasmacytoid dendritic cells move down on the list of suspects: in search of the immune pathogenesis of chronic hepatitis C.
Albert ML; Decalf J; Pol S
J Hepatol; 2008 Dec; 49(6):1069-78. PubMed ID: 18929418
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis and treatment of autoimmune hepatitis and chronic viral hepatitis B and C.
Pár A
Acta Physiol Hung; 2000; 87(4):373-95. PubMed ID: 11732890
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis virus immune restoration disease of the liver.
Crane M; Matthews G; Lewin SR
Curr Opin HIV AIDS; 2008 Jul; 3(4):446-52. PubMed ID: 19373004
[TBL] [Abstract][Full Text] [Related]
16. Role of regulatory T-cells during hepatitis C infection: From the acute phase to post-transplantation recurrence.
Barjon C; Dahlqvist G; Calmus Y; Conti F
Dig Liver Dis; 2015 Nov; 47(11):913-7. PubMed ID: 26216068
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C.
Losikoff PT; Self AA; Gregory SH
Virulence; 2012 Nov; 3(7):610-20. PubMed ID: 23076334
[TBL] [Abstract][Full Text] [Related]
18. DNA vaccine therapy for chronic hepatitis C virus (HCV) infection: immune control of a moving target.
Sällberg M; Frelin L; Weiland O
Expert Opin Biol Ther; 2009 Jul; 9(7):805-15. PubMed ID: 19527105
[TBL] [Abstract][Full Text] [Related]
19. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
[TBL] [Abstract][Full Text] [Related]
20. TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C.
Askar E; Bregadze R; Mertens J; Schweyer S; Rosenberger A; Ramadori G; Mihm S
J Med Virol; 2009 Jul; 81(7):1204-11. PubMed ID: 19475618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]